Children's National Research Institute
childrensnational.orgTotal trials
119
Active
52
Phase 3
3
Total enrollment
76,176
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 18 of 18 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| normal saline | — | — | — | — | — | 2 | |
| Omalizumab | — | — | — | — | — | 1 | |
| Somatropin | — | — | — | — | — | 1 | |
| Amicar | — | — | — | — | — | 1 | |
| Daratumumab | — | — | — | — | — | 1 | |
| Alemtuzumab | — | — | — | — | — | 1 | |
| Sirolimus | — | — | — | — | — | 1 | |
| Selective Antigen Specific dTβRII-expressing T cells combined with B7-H3 CAR T cells | — | — | — | — | — | 1 | |
| Dexamethasone | — | — | — | — | — | 1 | |
| Coronavirus-specific T cell | — | — | — | — | — | 1 | |
| Multi-tumor antigen specific cytotoxic T lymphocytes | — | — | — | — | — | 1 | |
| Group A Standard-of-Care Backbone Therapy | — | — | — | — | — | 1 | |
| Tumor associated antigen lymphocytes | — | — | — | — | — | 1 | |
| Norovirus -specific T-cell (NST) therapy | — | — | — | — | — | 1 | |
| Tumor-associated antigen-specific T cell | — | — | — | — | — | 1 | |
| Virus Specific T cells | — | — | — | — | — | 1 | |
| Nivolumab | — | — | — | — | 2 | ||
| SGT-53 | — | — | — | — | — | 1 |
Next readouts
- 2022-04-18
- 2023-09-01
- 2025-12-01
- 2026-03
- 2028-01
- 2028-01-01
- 2028-05-01
- 2028-08-30
- 2028-10
- 2028-11-01
Top conditions
- Sickle Cell Disease7
- Rhabdomyosarcoma3
- Ewing Sarcoma3
- Wilms Tumor3
- Type 1 Diabetes3
- Autism Spectrum Disorder3
- Pain3
- Pediatric ALL3
Frequently asked questions about Children's National Research Institute
- How many clinical trials does Children's National Research Institute have on ClinicalTrials.gov?
- Children's National Research Institute is listed as the lead sponsor on 119 clinical trials in ClinicalTrials.gov, 52 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Children's National Research Institute's trials are in Phase 3?
- 3 of Children's National Research Institute's trials are in Phase 3, spread across 18 active drug programs.
- What therapeutic areas does Children's National Research Institute focus on?
- Children's National Research Institute's most-studied conditions on ClinicalTrials.gov are Sickle Cell Disease, Rhabdomyosarcoma, Ewing Sarcoma, Wilms Tumor, Type 1 Diabetes.
- When are Children's National Research Institute's next clinical trial readouts?
- Children's National Research Institute has 10 upcoming primary-completion readouts tracked here; the soonest is “Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors”, expected around 2022-04-18.